Posts attached with hashtag: #curemeso
Hong Kong researchers have released the first results of an experimental mesothelioma treatment they are working on. The treatment targets organic compounds believed to contribute to mesothelioma growth. ⠀⠀⠀⠀⠀⠀⠀⠀⠀ July 6, 2019 - Alex Strauss ⠀⠀⠀⠀⠀⠀⠀⠀⠀ www.survivingmesothelioma.com/experimental-mesothelioma-treatment
Supporting our Local 17 Insulators at this year’s DuPage Building Trades Golf Outing!
Happy Independence Day to our American #mesothelioma warriors and family! 🇺🇸🎉#curemeso
Wishing a Happy Canada Day to our Canadian #mesothelioma warriors and family! 🇨🇦 #curemeso
Daddy’s day was different this year, but we got to go say hi to him and to the other daddy’s there. Brittany is having a go, but is staying as positive as she can, but is letting herself still to feel the good and hardships. Love you daddy. #fathersday #curemeso #missyou #firstfathersdaywithoutyou #servicedog #medicalalert #webewarrior #tahomanationalcemetery #blessed #savingmyhuman #diamondintheruff #pjsavestheday #webewarrior #servicewebe
UK scientists are testing a breathalyzer for earlier mesothelioma detection. ・ A UK-based medical manufacturer has announced that it will start running clinical trials to test whether a disease breathalyzer can detect malignant mesothelioma before the disease’s symptoms start to appear. ・ Cambridge-based Owlstone Medical will be partnering with the International Association of Heat and Frost Insulators and Allied Workers (IAHFIAW) in the U.S. and Canada. IAHFIAW members are at high risk of developing mesothelioma. ・ Those who work in construction and manufacturing are at particularly high risk of asbestos exposure and mesothelioma, according to Vogelzang Law. But because of the disease’s lengthy latency period of 40-50 years, mesothelioma can be difficult to diagnose until it’s in its later stages. ・ According to Owlstone’s press release, the company will be testing the device, known as Breath Biopsy. The device will analyze various chemicals found in IAHFIAW members who have documented exposure to asbestos and have confirmed malignant mesothelioma. ・ The project will be divided into two phases. First, scientists will identify the volatile organic compounds (VOCs) in the participants’ breath. The next step will be to conduct a blind study to determine whether present biomarkers are predictive of having the disease. ・ All of the breath samples will be collected using the ReCIVA Breath Sampler from Owlstone Medical. The samples will be analyzed at the company’s Breath Biopsy Laboratory in Cambridge. ・ The study is expected to last three years and is being partly funded by the non-profit organization Tissue Bank Asbestos Research Charitable Trust. ・ Earlier diagnosis of malignant mesothelioma can lead to more effective treatment and a longer life. Currently, early detection of the disease is challenging, which leads to poor prognosis for patients. ・ “Through this partnership, we are looking not only to advance the early diagnosis of malignant mesothelioma, but also to demonstrate that breath-based screening has the potential to have a substantial impact on a wide range of environment-driven disease,” said Billy Boyle, founder of Owlstone Medical.
We had a great time Thanks to #jfcbreathefreefoundation MY GUY FITNESS was able to help contribute and spread awareness to help find a cure for mesothelioma 🙏 #believeinacure #mesotheliomaawareness #jfcbreathefreefoundation #curemeso #myguyfitness #myguycertified #myguyfamily #myguyathlete #MGF #athlete #gym #motivation #golftournement #passion #gains #gym #motivator #gymmemes #fitness #fitfam #donation #summer2k19 #golf #support And remember, why be that guy when you can be MY GUY 💪